These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17290340)

  • 1. [Side effects of treatment with the long-acting gonadorelin agonist triptorelin in a case of paraphilia].
    Hoogeveen JH; van der Veer E
    Tijdschr Psychiatr; 2007; 49(2):111-5. PubMed ID: 17290340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia.
    Hoogeveen J; Van der Veer E
    J Sex Med; 2008 Mar; 5(3):626-30. PubMed ID: 17971105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal pharmacotherapy: balancing between politics and evidence-based medicine].
    van Panhuis PJ
    Tijdschr Psychiatr; 2007; 49(2):117-8. PubMed ID: 17290341
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urolithiasis in the Long-Term GnRH Agonist Treatment of Patients with Paraphilia: 3 Case Studies].
    Mayrhofer G; Wegner D; Voß T
    Aktuelle Urol; 2016 Dec; 47(6):487-490. PubMed ID: 27701680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of men with paraphilia.
    Bradford JM
    N Engl J Med; 1998 Feb; 338(7):464-5. PubMed ID: 9459652
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged flare-up of testosterone after administration of a gonadotrophin agonist to a sex offender: an under-recognised risk?
    Huygh J; Verhaegen A; Goethals K; Cosyns P; De Block C; Van Gaal L
    Crim Behav Ment Health; 2015 Jul; 25(3):226-30. PubMed ID: 25851640
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.
    Briken P; Hill A; Berner W
    J Clin Psychiatry; 2003 Aug; 64(8):890-7. PubMed ID: 12927003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotrophin-releasing hormone agonists induce osteoporosis.
    Maillefert JF; Sibilia J; Kuntz JL; Tavernier C
    Br J Rheumatol; 1994 Dec; 33(12):1199-200. PubMed ID: 8000764
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic treatment of paraphilias.
    Assumpção AA; Garcia FD; Garcia HD; Bradford JM; Thibaut F
    Psychiatr Clin North Am; 2014 Jun; 37(2):173-81. PubMed ID: 24877704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hair loss in children on long-acting gonadotropin-releasing hormone agonist triptorelin treatment.
    Kauschansky A; Lurie R; Ingber A
    Acta Derm Venereol; 1997 Jul; 77(4):333. PubMed ID: 9228240
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone.
    Rösler A; Witztum E
    N Engl J Med; 1998 Feb; 338(7):416-22. PubMed ID: 9459644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.
    Thibaut F; Cordier B; Kuhn JM
    Acta Psychiatr Scand; 1993 Jun; 87(6):445-50. PubMed ID: 8356897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription of testosterone-lowering medications for sex offender treatment in German forensic-psychiatric institutions.
    Turner D; Basdekis-Jozsa R; Briken P
    J Sex Med; 2013 Feb; 10(2):570-8. PubMed ID: 23088739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting triptorelin for the treatment of endometriosis.
    Choktanasiri W; Boonkasemsanti W; Sittisomwong T; Kunathikom S; Suksompong S; Udomsubpayakul U; Rojanasakul A
    Int J Gynaecol Obstet; 1996 Sep; 54(3):237-43. PubMed ID: 8889631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin.
    Roux C; Pelissier C; Listrat V; Kolta S; Simonetta C; Guignard M; Dougados M; Amor B
    Osteoporos Int; 1995 May; 5(3):185-90. PubMed ID: 7655179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-onset psychosis following androgen deprivation therapy for prostate cancer.
    Bernad DM; Dal Pra A; Baule C; Frey BN; Faria S
    Can J Urol; 2013 Aug; 20(4):6868-70. PubMed ID: 23930615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism.
    Rousseau L; Couture M; Dupont A; Labrie F; Couture N
    Can J Psychiatry; 1990 May; 35(4):338-41. PubMed ID: 2189544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment.
    Antoniazzi F; Bertoldo F; Lauriola S; Sirpresi S; Gasperi E; Zamboni G; Tatò L
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1992-6. PubMed ID: 10372699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: the management of bone demineralization associated with long-term treatment of multiple paraphilias with long-acting LHRH agonists.
    Dickey R
    J Sex Marital Ther; 2002; 28(3):207-10. PubMed ID: 11995599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.